The Clinical Characteristics of Obese Patients with Acanthosis Nigricans and Its Independent Risk Factors

Yueye Huang; Jiaqi Chen; Xingchun Wang; Yan Li; Shezhen Yang; Shen Qu

doi:10.1055/s-0042-123035

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2017; 125(03): 191-195
DOI: 10.1055/s-0042-123035

Article

The Clinical Characteristics of Obese Patients with Acanthosis Nigricans and Its Independent Risk Factors

Yueye Huang

¹Department of Endocrinology and Metabolism, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

,

Jiaqi Chen

¹Department of Endocrinology and Metabolism, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

,

Xingchun Wang

¹Department of Endocrinology and Metabolism, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

,

Yan Li

¹Department of Endocrinology and Metabolism, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

,

Shezhen Yang

²Department of Endocrinology, Haimen People’s Hospital, Jiangsu, China

,

Shen Qu

¹Department of Endocrinology and Metabolism, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, China

› Author Affiliations

Abstract

Objective: This study aimed to investigate the clinical characteristics and risk factors for acanthosis nigricans (AN) in obese patients.

Methods: 80 obese patients without AN (OB group) and 128 obese patients with AN (AN group) were included in this study. Clinical data for each patients were collected. Serum levels of leptin were measured by ELISA.

Results: Body mass index (BMI), uric acid (UA) levels, fasting insulin, and HOMA-IR were higher in AN than OB (P<0.05). The levels of leptin were significantly higher in AN than OB (P<0.001) after adjustment for BMI and gender. In male patients, AN showed lower serum levels of testosterone than OB (P<0.001). Multiple Logistic-regression analysis demonstrated that UA (OR 4.627, 95%CI 2.443–8.762, P<0.001) and Leptin (OR 4.098, 95%CI 1.237–13.581, P=0.021) were independent risk factors for AN. In addition, low testosterone level was an independent risk factor for AN in male obese patients (OR 39.062, 95%CI 5.523–283.808, P<0.001).

Conclusions: AN is associated with more severe hyperinsulinemia and hyperuricemia in obese patients, as well as lower serum testosterone levels in male patients. UA and Leptin were independent risk factors for AN in obese patients. Low testosterone may be a valuable predictor of AN in male obese patients.

Key words

obesity - acanthosis nigricans - insulin resistance - leptin - testosterone

Full Text

References

References
1 Ng M, Fleming T, Robinson M et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766-781
2 Jones LH, Ficca M. Is Acanthosis Nigricans a reliable indicator for risk of type 2 diabetes?. J Sch Nurs 2007; 23: 247-251
3 Sinha S, Schwartz RA. Juvenile acanthosis nigricans. J Am Acad Dermatol 2007; 57: 502-508
4 Kobaissi HA, Weigensberg MJ, Ball GD et al. Relation between acanthosis nigricans and insulin sensitivity in overweight Hispanic children at risk for type 2 diabetes. Diabetes Care 2004; 27: 1412-1416
5 Atwa M, Emara A, Balata M et al. Serum leptin, adiponectin, and resistin among adult patients with acanthosis nigricans: correlations with insulin resistance and risk factors for cardiovascular disease. Int J Dermatol 2014; 53: e410-e420
6 Koerner A, Kratzsch J, Kiess W. Adipocytokines: leptin – the classical, resistin – the controversical, adiponectin – the promising, and more to come. Best Pract Res Clin Endocrinol Metab 2005; 19: 525-546
7 Zhang F, Chen Y, Heiman M et al. Leptin: structure, function and biology. Vitam Horm 2005; 71: 345-372
8 Polyzos SA, Kountouras J, Mantzoros CS. Leptin in nonalcoholic fatty liver disease: a narrative review. Metabolism 2015; 64: 60-78
9 Zhou Y, Rui L. Leptin signaling and leptin resistance. Front Med 2013; 7: 207-222
10 Allison MA, Lx JH, Morgan C et al. Higher leptin is associated with hypertension: the Multi-Ethnic Study of Atherosclerosis. J Hum Hypertens 2013; 27: 617-622
11 Ames BN, Cathcart R, Schwiers E et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 1981; 78: 6858-6862
12 Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids 2008; 27: 608-619
13 Kodama S, Saito K, Yachi Y et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009; 32: 1737-1742
14 Khosla UM, Zharikov S, Finch JL et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-1742
15 Chuengsamarn S, Rattanamongkolgul S, Jirawatnotai S. Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes. J Diabetes Complications 2014; 28: 124-129
16 Xia J, Wang Z, Zhang F. Association between Related Purine Metabolites and Diabetic Retinopathy in Type 2 Diabetic Patients. Int J Endocrinol 2014; 2014 651050
17 Li L, Yang C, Zhao Y et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol 2014; 15: 122
18 Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821
19 Daskalopoulou SS, Athyros VG, Elisaf M et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004; 66: 1714-1715
20 Burke JP, Hale DE, Hazuda HP et al. A quantitative scale of acanthosis nigricans. Diabetes Care 1999; 22: 1655-1659
21 Bonora E, Targher G, Alberiche M et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63
22 Hermanns-Le T, Scheen A, Pierard GE. Acanthosis nigricans associated with insulin resistance: pathophysiology and management. Am J Clin Dermatol 2004; 5: 199-203
23 Groschl M, Topf HG, Kratzsch J et al. Salivary leptin induces increased expression of growth factors in oral keratinocytes. J Mol Endocrinol 2005; 34: 353-366
24 Stallmeyer B, Kampfer H, Podda M et al. A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair. J Invest Dermatol 2001; 117: 98-105
25 Takahashi H, Honma M, Ishida-Yamamoto A et al. Adiponectin and leptin modulate cell proliferation and cytokine secretion of normal human keratinocytes and T lymphocytes. J Dermatol Sci 2010; 59: 143-145
26 Wei CY, Sun CC, Wei JC et al. Association between Hyperuricemia and Metabolic Syndrome: An Epidemiological Study of a Labor Force Population in Taiwan. Biomed Res Int 2015; 2015 369179
27 Johnson RJ. Why focus on uric acid?. Curr Med Res Opin 2015; 31 (Suppl. 02) 3-7
28 Su P, Hong L, Zhao Y et al. Relationship Between Hyperuricemia and Cardiovascular Disease Risk Factors in a Chinese Population: A Cross-Sectional Study. Med Sci Monit 2015; 21: 2707-2717
29 Lima WG, Martins-Santos ME, Chaves VE. Uric acid as a modulator of glucose and lipid metabolism. Biochimie 2015; 116: 17-23
30 Liu P, Chen Y, Wang B et al. Allopurinol treatment improves renal function in patients with type 2 diabetes and asymptomatic hyperuricemia: 3-year randomized parallel-controlled study. Clin Endocrinol (Oxf) 2015; 83: 475-482
31 Kleikamp S, Bohm M, Frosch P et al. Acanthosis nigricans, papillomatosis mucosae and “tripe palms” in a patient with metastasized gastric carcinoma. Dtsch Med Wochenschr 2006; 131: 1209-1213
32 Bo S, Cavallo-Perin P, Gentile L et al. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 2001; 31: 318-321
33 Rotter I, Kosik-Bogacka D, Dolegowska B et al. Analysis of relationships between the concentrations of total testosterone and dehydroepiandrosterone sulfate and the occurrence of selected metabolic disorders in aging men. Aging Male 2015; 18: 249-255
34 Wickramatilake CM, Mohideen MR, Pathirana C. Association of metabolic syndrome with testosterone and inflammation in men. Ann Endocrinol (Paris) 2015; 76: 260-263
35 Dhindsa S, Ghanim H, Batra M et al. Insulin Resistance and inflammation in hypogonadotropic hypogonadism and their reduction after testosterone replacement in men with type 2 diabetes. Diabetes Care 2016; 39: 82-91
36 De Pergola G, Pannacciulli N, Ciccone M et al. Free testosterone plasma levels are negatively associated with the intima-media thickness of the common carotid artery in overweight and obese glucose-tolerant young adult men. Int J Obes Relat Metab Disord 2003; 27: 803-807
37 Cooper LA, Page ST, Amory JK et al. The association of obesity with sex hormone-binding globulin is stronger than the association with ageing – implications for the interpretation of total testosterone measurements. Clin Endocrinol (Oxf) 2015; 83: 828-833
38 Peter A, Kantartzis K, Machann J et al. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes 2010; 59: 3167-3173